Abstracts from the 2024 WDS Forum - Virtual Option

May 2025 in “ International Journal of Women’s Dermatology ”

5-alpha reductase inhibitors spironolactone minoxidil glucagon-like-peptide-1 receptor agonists alopecia hidradenitis suppurativa metformin LNG-IUDs machine learning basal cell carcinoma JAK-inhibitors CCCA autoimmune involvement 5-ARI Rogaine GLP-1 receptor agonists hair loss hormonal treatment contraceptive IUD artificial intelligence skin cancer central centrifugal cicatricial alopecia

Studysummary In this retrospective cohort study, researchers found that exposure to 5-alpha reductase inhibitors and spironolactone in female alopecia patients was not linked to an increased risk of developing malignant or benign gynecologic tumors when compared to minoxidil use.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on journals.lww.com →

Discuss this study in the Community →

Similar research 5

Clinical Updates in Hair Dermatologic Clinics · 1997
Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity Current Issues in Molecular Biology · 2025
Regulation of Hair Growth JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 1997
Combination Oral Minoxidil and Spironolactone for the Treatment of Androgenetic Alopecia in Adolescent Females 2020
Alopecia: Unapproved Treatments or Indications Clinics in Dermatology · 2000

Related Community Posts Join

6 / 1000+ results

community Oral minoxidil (loniten) and Spironolactone

4 upvotes 4 years ago

Oral minoxidil (Loniten) and topical spironolactone are discussed for hair loss treatment, with mixed results and potential side effects like unwanted body hair. Finasteride is suggested as a better alternative for men, and dosages for oral minoxidil range from 2.5 mg to 5 mg daily.

community 6 weeks minoxidil… and spironolactone

33 upvotes 11 months ago

Minoxidil and spironolactone are used for hair regrowth, with visible progress noted. Spironolactone is discussed as a treatment option, particularly in the context of transitioning, with concerns about its effects on men.

community 5 months topical spiro + minox + micro

6 upvotes 1 year ago

A 35-year-old male uses topical minoxidil, spironolactone, and microneedling for hair loss, with spironolactone prescribed based on a DNA test indicating poor response to finasteride and dutasteride. Despite concerns about the test's validity and spironolactone's side effects, he reports stable or improved hair condition and no low testosterone symptoms.

community How effective is topical spironolactone for androgenic alopecia?

in Female 1 upvotes 1 year ago

Topical spironolactone is discussed as a potential treatment for androgenic alopecia, with the user seeking feedback on its effectiveness. Minoxidil, finasteride, and other treatments like microneedling and keto shampoo are mentioned as alternatives.

community Are any of you using topical spironolactone ?

in Treatment 4 upvotes 1 year ago

The user is using topical dutasteride, minoxidil, and spironolactone for hair loss, with positive results after adding spironolactone. Another user takes oral spironolactone, dutasteride, and finasteride, noting decreased libido but no major side effects.

community Minoxidil is a 5ar inhibitor according to research

150 upvotes 11 months ago

Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.